Wilhelm Bone

USPTO Granted Patents = 20 (Patent Applications = 8)

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 15 (Patent Applications = 26)

Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 44(Granted Patents)

Company Filing History:

11 out of 378

Bayer Pharma Aktiengesellschaft

patents

8 out of 721

Bayer Intellectual Property Gmbh

patents

1 out of 12,157

Bayer Aktiengesellschaft

patents

4. 1 out of 1,206

Dana-farber-cancer Institute Inc.

patents

5. 1 out of 443

The Broad Institute, Inc.

patents

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

20 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12227501 - 3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitors (2025-02-18),

2. 11529356 - 2-(morpholin-4-yl)-1,7-naphthyridines (2022-12-20),

3. 10894784 - Heteroarylbenzimidazole compounds (2021-01-19),

4. 10772893 - 2-(morpholin-4-yl)-1,7-naphthyridines (2020-09-15),

5. 10428044 - 3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones (2019-10-01),

6. 10350206 - Benzyl substituted indazoles as BUB1 inhibitors (2019-07-16),

7. 10155004 - 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases (2018-12-18),

8. 9993484 - 2-(morpholin-4-yl)-1,7-naphthyridines (2018-06-12),

9. 9765058 - Substituted benzylpyrazoles (2017-09-19),

10. 9745285 - Heteroaryl substituted pyrazoles (2017-08-29),

11. 9717739 - 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases (2017-08-01),

12. 9682974 - Heteroaryl substituted pyrazoles (2017-06-20),

13. 9549932 - 2-(morpholin-4-yl)-1,7-naphthyridines (2017-01-24),

14. 9206219 - 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseases (2015-12-08),

15. 9156877 - 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzylidene derivatives, methods for the production thereof and use thereof for treating diseases (2015-10-13),

Title: Wilhelm Bone: A Trailblazer in Innovation

Introduction:

Wilhelm Bone, a visionary inventor based in Berlin, Germany, has left an indelible mark on the world of technological advancements. His unwavering dedication to innovation continues to inspire budding inventors globally.

Latest Patents:

With an impressive portfolio of 19 patents, Wilhelm Bone has recently unveiled groundbreaking inventions. One of his latest patents is the development of substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds, revolutionizing the treatment and prophylaxis of hyperproliferative diseases. Additionally, his work on heteroarylbenzimidazole compounds has paved the way for novel pharmaceutical compositions targeting inflammatory disorders.

Career Highlights:

Having worked at renowned companies such as Bayer Pharma Aktiengesellschaft and Bayer Intellectual Property GmbH, Wilhelm Bone has seamlessly integrated cutting-edge research with practical applications. His innovative spirit and scientific acumen have propelled him to the forefront of the industry.

Collaborations:

Throughout his career, Wilhelm Bone has collaborated with esteemed colleagues such as Hans Briem and Ulrich Klar. Together, they have pushed the boundaries of innovation, setting new standards for excellence in the field of patents and inventions.

Conclusion:

In conclusion, Wilhelm Bone's remarkable journey as an inventor epitomizes the essence of relentless pursuit of excellence in the realm of technological innovation. His contributions have not only reshaped the landscape of patents and inventions but also continue to inspire future generations to dream, create, and innovate.

This text is generated by artificial intelligence and may not be accurate.